Decline in Presumptively Protective Gut Bacterial Species and Metabolites Are Paradoxically Associated with Disease Improvement in Pediatric Crohn’s Disease During Enteral Nutrition
The gut microbiota is implicated in the pathogenesis of Crohn’s disease (CD). Exclusive enteral nutrition (EEN) is a successful treatment, but its mode of action remains unknown. This study assessed serial changes in the fecal microbiota milieu during EEN.MethodsFive fecal samples were collected fro...
Saved in:
Published in | Inflammatory bowel diseases Vol. 20; no. 5; pp. 861 - 871 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Oxford University Press
01.05.2014
|
Subjects | |
Online Access | Get full text |
ISSN | 1078-0998 1536-4844 1536-4844 |
DOI | 10.1097/MIB.0000000000000023 |
Cover
Abstract | The gut microbiota is implicated in the pathogenesis of Crohn’s disease (CD). Exclusive enteral nutrition (EEN) is a successful treatment, but its mode of action remains unknown. This study assessed serial changes in the fecal microbiota milieu during EEN.MethodsFive fecal samples were collected from CD children: 4 during EEN (start, 15, 30, end EEN approximately 60 days) and the fifth on habitual diet. Two samples were collected from healthy control subjects. Fecal pH, bacterial metabolites, global microbial diversity abundance, composition stability, and quantitative changes of total and 7 major bacterial groups previously implicated in CD were measured.ResultsOverall, 68 samples were from 15 CD children and 40 from 21 control subjects. Fecal pH and total sulfide increased and butyric acid decreased during EEN (all P < 0.05). Global bacterial diversity abundance decreased (P < 0.05); a higher degree of microbiota composition stability was seen in control subjects than in CD children during EEN (at P ≤ 0.008). Faecalibacterium prausnitzii spp concentration significantly decreased after 30 days on EEN (P < 0.05). In patients who responded to EEN, the magnitude of the observed changes was greater and the concentration of Bacteroides/Prevotella group decreased (P < 0.05). All these changes reverted to pretreatment levels on free diet, and EEN microbiota diversity increased when the children returned to their free diet.ConclusionsEEN impacts on gut microbiota composition and changes fecal metabolic activity. It is difficult to infer a causative association between such changes and disease improvement, but the results do challenge the current perception of a protective role for F. prausnitzii in CD. |
---|---|
AbstractList | The gut microbiota is implicated in the pathogenesis of Crohn’s disease (CD). Exclusive enteral nutrition (EEN) is a successful treatment, but its mode of action remains unknown. This study assessed serial changes in the fecal microbiota milieu during EEN.MethodsFive fecal samples were collected from CD children: 4 during EEN (start, 15, 30, end EEN approximately 60 days) and the fifth on habitual diet. Two samples were collected from healthy control subjects. Fecal pH, bacterial metabolites, global microbial diversity abundance, composition stability, and quantitative changes of total and 7 major bacterial groups previously implicated in CD were measured.ResultsOverall, 68 samples were from 15 CD children and 40 from 21 control subjects. Fecal pH and total sulfide increased and butyric acid decreased during EEN (all P < 0.05). Global bacterial diversity abundance decreased (P < 0.05); a higher degree of microbiota composition stability was seen in control subjects than in CD children during EEN (at P ≤ 0.008). Faecalibacterium prausnitzii spp concentration significantly decreased after 30 days on EEN (P < 0.05). In patients who responded to EEN, the magnitude of the observed changes was greater and the concentration of Bacteroides/Prevotella group decreased (P < 0.05). All these changes reverted to pretreatment levels on free diet, and EEN microbiota diversity increased when the children returned to their free diet.ConclusionsEEN impacts on gut microbiota composition and changes fecal metabolic activity. It is difficult to infer a causative association between such changes and disease improvement, but the results do challenge the current perception of a protective role for F. prausnitzii in CD. BackgroundThe gut microbiota is implicated in the pathogenesis of Crohn’s disease (CD). Exclusive enteral nutrition (EEN) is a successful treatment, but its mode of action remains unknown. This study assessed serial changes in the fecal microbiota milieu during EEN.MethodsFive fecal samples were collected from CD children: 4 during EEN (start, 15, 30, end EEN approximately 60 days) and the fifth on habitual diet. Two samples were collected from healthy control subjects. Fecal pH, bacterial metabolites, global microbial diversity abundance, composition stability, and quantitative changes of total and 7 major bacterial groups previously implicated in CD were measured.ResultsOverall, 68 samples were from 15 CD children and 40 from 21 control subjects. Fecal pH and total sulfide increased and butyric acid decreased during EEN (all P < 0.05). Global bacterial diversity abundance decreased (P < 0.05); a higher degree of microbiota composition stability was seen in control subjects than in CD children during EEN (at P ≤ 0.008). Faecalibacterium prausnitzii spp concentration significantly decreased after 30 days on EEN (P < 0.05). In patients who responded to EEN, the magnitude of the observed changes was greater and the concentration of Bacteroides/Prevotella group decreased (P < 0.05). All these changes reverted to pretreatment levels on free diet, and EEN microbiota diversity increased when the children returned to their free diet.ConclusionsEEN impacts on gut microbiota composition and changes fecal metabolic activity. It is difficult to infer a causative association between such changes and disease improvement, but the results do challenge the current perception of a protective role for F. prausnitzii in CD. The gut microbiota is implicated in the pathogenesis of Crohn's disease (CD). Exclusive enteral nutrition (EEN) is a successful treatment, but its mode of action remains unknown. This study assessed serial changes in the fecal microbiota milieu during EEN.BACKGROUNDThe gut microbiota is implicated in the pathogenesis of Crohn's disease (CD). Exclusive enteral nutrition (EEN) is a successful treatment, but its mode of action remains unknown. This study assessed serial changes in the fecal microbiota milieu during EEN.Five fecal samples were collected from CD children: 4 during EEN (start, 15, 30, end EEN approximately 60 days) and the fifth on habitual diet. Two samples were collected from healthy control subjects. Fecal pH, bacterial metabolites, global microbial diversity abundance, composition stability, and quantitative changes of total and 7 major bacterial groups previously implicated in CD were measured.METHODSFive fecal samples were collected from CD children: 4 during EEN (start, 15, 30, end EEN approximately 60 days) and the fifth on habitual diet. Two samples were collected from healthy control subjects. Fecal pH, bacterial metabolites, global microbial diversity abundance, composition stability, and quantitative changes of total and 7 major bacterial groups previously implicated in CD were measured.Overall, 68 samples were from 15 CD children and 40 from 21 control subjects. Fecal pH and total sulfide increased and butyric acid decreased during EEN (all P < 0.05). Global bacterial diversity abundance decreased (P < 0.05); a higher degree of microbiota composition stability was seen in control subjects than in CD children during EEN (at P ≤ 0.008). Faecalibacterium prausnitzii spp concentration significantly decreased after 30 days on EEN (P < 0.05). In patients who responded to EEN, the magnitude of the observed changes was greater and the concentration of Bacteroides/Prevotella group decreased (P < 0.05). All these changes reverted to pretreatment levels on free diet, and EEN microbiota diversity increased when the children returned to their free diet.RESULTSOverall, 68 samples were from 15 CD children and 40 from 21 control subjects. Fecal pH and total sulfide increased and butyric acid decreased during EEN (all P < 0.05). Global bacterial diversity abundance decreased (P < 0.05); a higher degree of microbiota composition stability was seen in control subjects than in CD children during EEN (at P ≤ 0.008). Faecalibacterium prausnitzii spp concentration significantly decreased after 30 days on EEN (P < 0.05). In patients who responded to EEN, the magnitude of the observed changes was greater and the concentration of Bacteroides/Prevotella group decreased (P < 0.05). All these changes reverted to pretreatment levels on free diet, and EEN microbiota diversity increased when the children returned to their free diet.EEN impacts on gut microbiota composition and changes fecal metabolic activity. It is difficult to infer a causative association between such changes and disease improvement, but the results do challenge the current perception of a protective role for F. prausnitzii in CD.CONCLUSIONSEEN impacts on gut microbiota composition and changes fecal metabolic activity. It is difficult to infer a causative association between such changes and disease improvement, but the results do challenge the current perception of a protective role for F. prausnitzii in CD. Background: The gut microbiota is implicated in the pathogenesis of Crohn's disease (CD). Exclusive enteral nutrition (EEN) is a successful treatment, but its mode of action remains unknown. This study assessed serial changes in the fecal microbiota milieu during EEN. Methods: Five fecal samples were collected from CD children: 4 during EEN (start, 15, 30, end EEN approximately 60 days) and the fifth on habitual diet. Two samples were collected from healthy control subjects. Fecal pH, bacterial metabolites, global microbial diversity abundance, composition stability, and quantitative changes of total and 7 major bacterial groups previously implicated in CD were measured. Results: Overall, 68 samples were from 15 CD children and 40 from 21 control subjects. Fecal pH and total sulfide increased and butyric acid decreased during EEN (all P < 0.05). Global bacterial diversity abundance decreased (P < 0.05); a higher degree of microbiota composition stability was seen in control subjects than in CD children during EEN (at P [< or =] 0.008). Faecalibacterium prausnitzii spp concentration significantly decreased after 30 days on EEN (P < 0.05). In patients who responded to EEN, the magnitude of the observed changes was greater and the concentration of Bacteroides/Prevotella group decreased (P < 0.05). All these changes reverted to pretreatment levels on free diet, and EEN microbiota diversity increased when the children returned to their free diet. Conclusions: EEN impacts on gut microbiota composition and changes fecal metabolic activity. It is difficult to infer a causative association between such changes and disease improvement, but the results do challenge the current perception of a protective role for F. prausnitzii in CD. The gut microbiota is implicated in the pathogenesis of Crohn's disease (CD). Exclusive enteral nutrition (EEN) is a successful treatment, but its mode of action remains unknown. This study assessed serial changes in the fecal microbiota milieu during EEN. Five fecal samples were collected from CD children: 4 during EEN (start, 15, 30, end EEN approximately 60 days) and the fifth on habitual diet. Two samples were collected from healthy control subjects. Fecal pH, bacterial metabolites, global microbial diversity abundance, composition stability, and quantitative changes of total and 7 major bacterial groups previously implicated in CD were measured. Overall, 68 samples were from 15 CD children and 40 from 21 control subjects. Fecal pH and total sulfide increased and butyric acid decreased during EEN (all P < 0.05). Global bacterial diversity abundance decreased (P < 0.05); a higher degree of microbiota composition stability was seen in control subjects than in CD children during EEN (at P ≤ 0.008). Faecalibacterium prausnitzii spp concentration significantly decreased after 30 days on EEN (P < 0.05). In patients who responded to EEN, the magnitude of the observed changes was greater and the concentration of Bacteroides/Prevotella group decreased (P < 0.05). All these changes reverted to pretreatment levels on free diet, and EEN microbiota diversity increased when the children returned to their free diet. EEN impacts on gut microbiota composition and changes fecal metabolic activity. It is difficult to infer a causative association between such changes and disease improvement, but the results do challenge the current perception of a protective role for F. prausnitzii in CD. |
Author | Garrick, Vikki Bertz, Martin McGrogan, Paraic Gerasimidis, Konstantinos Hanske, Laura Junick, Jana Blaut, Michael Aguilera, Margarita Russell, Richard K. Biskou, Olga Edwards, Christine A. |
Author_xml | – sequence: 1 givenname: Konstantinos surname: Gerasimidis fullname: Gerasimidis, Konstantinos organization: Human Nutrition, School of Medicine, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom – sequence: 2 givenname: Martin surname: Bertz fullname: Bertz, Martin organization: Human Nutrition, School of Medicine, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom – sequence: 3 givenname: Laura surname: Hanske fullname: Hanske, Laura organization: ‡Department of Gastrointestinal Microbiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee, Nuthetal, Germany – sequence: 4 givenname: Jana surname: Junick fullname: Junick, Jana organization: ‡Department of Gastrointestinal Microbiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee, Nuthetal, Germany – sequence: 5 givenname: Olga surname: Biskou fullname: Biskou, Olga organization: Human Nutrition, School of Medicine, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom – sequence: 6 givenname: Margarita surname: Aguilera fullname: Aguilera, Margarita organization: §Department of Microbiology, Faculty of Pharmacy, University of Granada, Campus Universitario de Cartuja, Granada, Spain – sequence: 7 givenname: Vikki surname: Garrick fullname: Garrick, Vikki organization: †Department of Pediatric Gastroenterology, Hepatology and Nutrition, National Health Service Scotland, Royal Hospital for Sick Children, Glasgow, United Kingdom – sequence: 8 givenname: Richard K. surname: Russell fullname: Russell, Richard K. organization: Human Nutrition, School of Medicine, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom – sequence: 9 givenname: Michael surname: Blaut fullname: Blaut, Michael organization: ‡Department of Gastrointestinal Microbiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee, Nuthetal, Germany – sequence: 10 givenname: Paraic surname: McGrogan fullname: McGrogan, Paraic organization: Human Nutrition, School of Medicine, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom – sequence: 11 givenname: Christine A. surname: Edwards fullname: Edwards, Christine A. organization: Human Nutrition, School of Medicine, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24651582$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks1u1DAQxy1URD_gDRCyxIVLWjuxE4fbdrctK7VQCThbjjNLXSV28Eeht74GT8L78CR42RaJvRT74Bnp9__P2J59tGOdBYReUnJISdscXSyPD8k_q6yeoD3Kq7pggrGdHJNGFKRtxS7aD-E6E3m3z9BuyWpOuSj30M8F6MFYwMbiSw8hjVM0NzDc5sxF0OsEn6WIj5WO4I0a8McJtIGAle3xBUTVucHEnM884EvlVe--G62GbDELwWmjIvT4m4lXeGECqAB4OU7e3cAINv6pC32GvNF47t2V_XX3I_xFF8kb-wWf2Fw8136fMheNs8_R05UaAry4Pw_Q59OTT_N3xfmHs-V8dl5oxlksaEv6ugRgoqRU1UxQIRhveMdXnSi5AiG6tuI50ESwhlelqvpWN1yDVkTQ6gC92fjmjr8mCFGOJmgYBmXBpSBpLUg2JKR-HOVU1FRUdZPR11votUve5ovIitatICUjJFOv7qnUjdDLyZtR-Vv58HsZeLsBtHcheFhJbaJaP0_0ygySErkeFZlHRW6PShazLfGD_yOyo43Mpen_FL8BQFXP2w |
CitedBy_id | crossref_primary_10_1016_j_jpeds_2017_08_077 crossref_primary_10_1111_jvim_16846 crossref_primary_10_1111_nmo_70012 crossref_primary_10_1136_flgastro_2020_101429 crossref_primary_10_3390_biomedicines12040897 crossref_primary_10_1097_MIB_0000000000000071 crossref_primary_10_1177_2472630320969147 crossref_primary_10_1017_S0029665121002846 crossref_primary_10_1007_s11306_022_01953_0 crossref_primary_10_1016_j_chom_2015_09_008 crossref_primary_10_3390_nu16213581 crossref_primary_10_1007_s11882_015_0538_9 crossref_primary_10_1097_MPG_0000000000002611 crossref_primary_10_1186_s40168_024_01834_9 crossref_primary_10_1371_journal_pone_0197649 crossref_primary_10_3389_fped_2021_610275 crossref_primary_10_3390_nu13020655 crossref_primary_10_3748_wjg_v22_i3_1045 crossref_primary_10_1016_j_gastha_2021_12_008 crossref_primary_10_1146_annurev_immunol_032414_112151 crossref_primary_10_1007_s10048_024_00791_7 crossref_primary_10_1002_ncp_10011 crossref_primary_10_3390_microorganisms11020505 crossref_primary_10_1097_MD_0000000000007347 crossref_primary_10_1097_MOG_0000000000000216 crossref_primary_10_1177_1756283X16644242 crossref_primary_10_1053_j_gastro_2020_08_007 crossref_primary_10_3390_nu13051611 crossref_primary_10_1097_MOG_0000000000000178 crossref_primary_10_1177_0884533615606898 crossref_primary_10_3389_fped_2017_00096 crossref_primary_10_1039_C5FO01196E crossref_primary_10_3390_nu15071742 crossref_primary_10_1002_jpn3_12258 crossref_primary_10_1159_000510646 crossref_primary_10_1002_jpen_1938 crossref_primary_10_3390_nu10050537 crossref_primary_10_1097_MOG_0000000000000585 crossref_primary_10_3390_ijms222212506 crossref_primary_10_3390_nu14010004 crossref_primary_10_1097_MPG_0000000000001785 crossref_primary_10_1016_j_jinf_2018_10_005 crossref_primary_10_1007_s00281_017_0658_5 crossref_primary_10_3748_wjg_v21_i22_6809 crossref_primary_10_1053_j_gastro_2015_01_007 crossref_primary_10_1371_journal_pone_0172605 crossref_primary_10_3390_nu11050947 crossref_primary_10_1002_jpen_2188 crossref_primary_10_3390_nu12123793 crossref_primary_10_14309_ajg_0000000000000641 crossref_primary_10_1093_ibd_izy080 crossref_primary_10_1146_annurev_nutr_061121_090535 crossref_primary_10_1016_j_ijmm_2021_151513 crossref_primary_10_1016_j_phrs_2019_104442 crossref_primary_10_1007_s00394_019_02161_8 crossref_primary_10_1093_ibd_izz297 crossref_primary_10_1111_imr_12826 crossref_primary_10_1097_MIB_0000000000000079 crossref_primary_10_3389_frmbi_2023_1192316 crossref_primary_10_1038_nrgastro_2015_11 crossref_primary_10_1111_apt_14384 crossref_primary_10_5217_ir_2019_00078 crossref_primary_10_1097_MIB_0000000000000590 crossref_primary_10_11131_2016_101199 crossref_primary_10_1128_mmbr_00127_22 crossref_primary_10_17235_reed_2017_5116_2017 crossref_primary_10_1016_j_cgh_2020_05_026 crossref_primary_10_1016_j_clnu_2018_01_020 crossref_primary_10_1016_j_giec_2022_04_003 crossref_primary_10_1016_j_jcmgh_2019_01_007 crossref_primary_10_1053_j_gastro_2018_12_002 crossref_primary_10_1186_s40168_019_0740_4 crossref_primary_10_5217_ir_2019_00075 crossref_primary_10_1128_AAC_04506_14 crossref_primary_10_1155_2017_8102589 crossref_primary_10_3389_fimmu_2023_1298186 crossref_primary_10_1007_s10067_016_3238_5 crossref_primary_10_1002_jpn3_12196 crossref_primary_10_1007_s00284_022_02899_1 crossref_primary_10_1177_17562848211064489 crossref_primary_10_1007_s12328_021_01510_7 crossref_primary_10_1093_ecco_jcc_jjx109 crossref_primary_10_1097_MIB_0000000000000949 crossref_primary_10_1111_jvim_16125 crossref_primary_10_1186_s13099_021_00448_y crossref_primary_10_1038_ajg_2015_357 crossref_primary_10_1080_19490976_2023_2297864 crossref_primary_10_1097_MCG_0000000000000772 crossref_primary_10_1111_apt_13248 crossref_primary_10_1007_s11897_016_0285_9 crossref_primary_10_1021_acs_analchem_7b01391 crossref_primary_10_1038_ctg_2014_21 crossref_primary_10_1016_j_clnu_2020_04_012 crossref_primary_10_3390_nu9080832 crossref_primary_10_1017_S0029665115002335 crossref_primary_10_1053_j_gastro_2019_08_015 crossref_primary_10_1016_S2352_4642_17_30017_2 crossref_primary_10_1016_j_dld_2020_10_033 crossref_primary_10_1017_S0007114523000405 crossref_primary_10_12998_wjcc_v9_i36_11122 crossref_primary_10_1111_apt_17720 crossref_primary_10_1136_archdischild_2020_320875 crossref_primary_10_1016_j_clim_2020_108415 crossref_primary_10_1038_ajg_2016_169 crossref_primary_10_1016_j_ajcnut_2023_12_027 crossref_primary_10_1007_s11938_019_00221_w crossref_primary_10_3390_nu13051533 crossref_primary_10_1016_j_clnu_2024_04_010 crossref_primary_10_1093_ecco_jcc_jjy207 crossref_primary_10_1159_000443360 crossref_primary_10_1038_ajg_2016_61 crossref_primary_10_1093_ecco_jcc_jjad063 crossref_primary_10_1146_annurev_physiol_031522_092054 crossref_primary_10_1038_s41598_020_77374_7 crossref_primary_10_1038_s41598_020_75306_z crossref_primary_10_1053_j_gastro_2015_08_006 crossref_primary_10_21926_rpn_2401003 crossref_primary_10_3390_antiox12081570 crossref_primary_10_3390_biology13090674 crossref_primary_10_5223_pghn_2021_24_5_432 crossref_primary_10_1097_MCO_0000000000001024 crossref_primary_10_1016_j_gtc_2017_08_012 crossref_primary_10_3389_fimmu_2025_1519925 crossref_primary_10_3390_ijerph20032152 crossref_primary_10_1016_j_eii_2016_06_003 crossref_primary_10_1128_AEM_02757_20 crossref_primary_10_1136_gutjnl_2017_315866 crossref_primary_10_1002_jpen_2392 crossref_primary_10_1016_j_gtc_2017_08_016 crossref_primary_10_3390_biomedicines12102340 crossref_primary_10_1002_jpen_1981 crossref_primary_10_1136_gutjnl_2015_309990 crossref_primary_10_1053_j_gastro_2022_05_050 crossref_primary_10_3390_nu14051053 crossref_primary_10_3390_nu9050447 crossref_primary_10_5493_wjem_v11_i1_1 crossref_primary_10_3389_fmed_2022_1036793 crossref_primary_10_1038_s41577_024_01014_8 crossref_primary_10_1039_D1FO03579G crossref_primary_10_3346_jkms_2021_36_e342 crossref_primary_10_1016_j_ebiom_2019_03_071 crossref_primary_10_1016_j_ebiom_2023_104959 crossref_primary_10_3390_nu13051628 crossref_primary_10_1136_bmjopen_2019_030659 crossref_primary_10_1007_s12161_014_9923_6 crossref_primary_10_3390_nu11092222 crossref_primary_10_1038_nrgastro_2017_88 crossref_primary_10_1186_s13104_016_2171_7 crossref_primary_10_3310_YCJD4579 crossref_primary_10_3390_nu12092551 crossref_primary_10_1093_ecco_jcc_jjad031 crossref_primary_10_1080_03036758_2019_1657471 crossref_primary_10_1038_ncomms13419 crossref_primary_10_1097_MCO_0000000000000402 crossref_primary_10_3390_nu15030668 crossref_primary_10_3390_nu6115298 crossref_primary_10_1080_10408398_2021_1912706 crossref_primary_10_1186_s12876_021_02029_4 crossref_primary_10_3389_fped_2021_626232 crossref_primary_10_1093_ibd_izad232 crossref_primary_10_1515_tnsci_2022_0354 crossref_primary_10_3934_microbiol_2018_4_584 crossref_primary_10_1016_j_jaci_2015_12_1331 crossref_primary_10_1093_femsre_fuw046 crossref_primary_10_3390_ijms17040578 crossref_primary_10_1038_s41575_022_00619_5 crossref_primary_10_1093_ecco_jcc_jjac079 crossref_primary_10_1111_1751_2980_12422 crossref_primary_10_1097_MOP_0000000000000660 crossref_primary_10_1111_apt_17451 crossref_primary_10_3390_nu12061691 crossref_primary_10_3390_nu16030363 crossref_primary_10_1097_MIB_0000000000000956 crossref_primary_10_3390_nu13010212 crossref_primary_10_1007_s11894_019_0668_7 |
Cites_doi | 10.3109/00365521.2012.703234 10.1016/0167-7012(92)90071-B 10.1073/pnas.0804812105 10.1002/ibd.21916 10.1016/S0899-9007(97)00493-0 10.1053/j.gastro.2007.08.041 10.1136/gut.41.1.77 10.1038/sj.bjp.0707193 10.1097/00005176-199105000-00005 10.1136/gut.52.2.237 10.1371/journal.pone.0057923 10.1053/j.gastro.2006.02.033 10.1111/j.1365-2036.2009.04067.x 10.1136/gut.2006.108449 10.1111/j.1572-0241.2006.01020.x 10.1053/j.gastro.2007.11.059 10.1177/01486071050290S4S173 10.1155/2005/269076 10.1007/s00394-004-0457-3 10.1111/j.1572-0241.1998.083_c.x 10.1023/A:1010661706385 10.1023/A:1018848709769 10.1097/01.MIB.0000200323.38139.c6 10.1371/journal.pone.0058825 10.1136/gut.38.6.870 10.1038/mi.2010.87 10.1079/PNS2003317 10.1016/j.dld.2012.04.014 10.1128/AEM.00508-07 10.1097/MCG.0b013e3181f39af5 10.1017/S0007114510001030 10.1111/apt.12230 10.1002/ibd.20903 10.1136/gut.41.1.70 10.1093/jn/135.8.1896 10.1111/j.1365-2036.2008.03796.x |
ContentType | Journal Article |
Copyright | Copyright © 2014 Crohn's & Colitis Foundation of America, Inc. 2014 Copyright © 2014 Crohn's & Colitis Foundation of America, Inc. |
Copyright_xml | – notice: Copyright © 2014 Crohn's & Colitis Foundation of America, Inc. 2014 – notice: Copyright © 2014 Crohn's & Colitis Foundation of America, Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7QL 7T5 C1K H94 |
DOI | 10.1097/MIB.0000000000000023 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Bacteriology Abstracts (Microbiology B) Immunology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management |
DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1536-4844 |
EndPage | 871 |
ExternalDocumentID | 24651582 10_1097_MIB_0000000000000023 10.1097/MIB.0000000000000023 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GrantInformation_xml | – fundername: Medical Research Council grantid: G0800675 |
GroupedDBID | --- .Z2 0R~ 1OC 3WU 48X 53G 5GY 5VS 5WD 66C 7O~ 8-0 8UM AAAXR AABZA AACZT AAKAS AAPQZ AAPXW AARHZ AARTV AAUAY AAVAP AAYEP ABBUW ABDFA ABEJV ABGNP ABJNI ABNHQ ABOCM ABPQP ABPTD ABQNK ABVGC ABWST ABXVJ ABXVV ABZAD ACDDN ACEWG ACGFO ACGFS ACUTJ ACWDW ACWRI ACXNZ ACYHN ADBBV ADBIZ ADGZP ADIPN ADQBN ADRTK ADVEK ADZCM AENEX AETBJ AFFZL AFOFC AFTRI AFUWQ AFXAL AGINJ AGQXC AGUTN AHMBA AHMMS AIJEX AIZYK AJEEA ALMA_UNASSIGNED_HOLDINGS ATGXG AWKKM BAYMD BCRHZ BEYMZ BOYCO BTRTY C45 CDBKE CS3 DAKXR DR2 DU5 E.X E3Z EBS EJD ENERS EX3 F5P FECEO FL- FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H0~ HZ~ IN~ IX1 KBUDW KOP KSI KSN LAW MHKGH NNB NOMLY NOYVH NVLIB N~7 N~B O9- OAUYM OCZFY ODMLO OIG OJZSN OPAEJ OVD OWPYF P2P PAFKI PQQKQ QRW ROX RUSNO RX1 S4S TEORI V2E WOW XV2 YAYTL YKOAZ YXANX ZFV 31~ 4.4 7X7 8-1 88E 8F7 8FI 8FJ AAJQQ AAPGJ AAUQX AAWDT AAYXX ABUWG ACFRR ACVCV ACXQS ACZBC ADMTO ADNBA AEMQT AFBPY AFFQV AFKRA AFYAG AFZJQ AGKRT AGMDO AGORE AHGBF AHRYX AJAOE AJBYB AJDVS AJNCP AJNYG ALXQX APJGH AQDSO AQKUS AVNTJ BENPR CCPQU CITATION EIHJH FYUFA H13 HMCUK IAO IHR ITC JXSIZ LH4 LW6 M1P MBLQV NU- OBFPC OCUKA ORVUJ PHGZM PHGZT PSQYO ROL TMA UKHRP W99 WOQ Y6R CGR CUY CVF ECM EIF NPM PJZUB PPXIY 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 7QL 7T5 C1K H94 |
ID | FETCH-LOGICAL-c454t-190d62ee48211a6481884575b5fb825ae88b9355aec0847532a3d9c75ceca0813 |
IEDL.DBID | 7X7 |
ISSN | 1078-0998 1536-4844 |
IngestDate | Thu Sep 04 18:02:52 EDT 2025 Thu Sep 04 23:57:49 EDT 2025 Fri Jul 25 21:50:50 EDT 2025 Mon Jul 21 05:53:16 EDT 2025 Tue Jul 01 04:19:45 EDT 2025 Thu Apr 24 23:00:34 EDT 2025 Sat Feb 08 08:13:07 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | enteral nutrition short-chain fatty acids gut microbiota pediatrics Crohn’s disease |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c454t-190d62ee48211a6481884575b5fb825ae88b9355aec0847532a3d9c75ceca0813 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://academic.oup.com/ibdjournal/article-pdf/20/5/861/23407434/ibd0861.pdf |
PMID | 24651582 |
PQID | 3169802400 |
PQPubID | 996336 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_1680457006 proquest_miscellaneous_1518618367 proquest_journals_3169802400 pubmed_primary_24651582 crossref_citationtrail_10_1097_MIB_0000000000000023 crossref_primary_10_1097_MIB_0000000000000023 oup_primary_10_1097_MIB_0000000000000023 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-05-01 |
PublicationDateYYYYMMDD | 2014-05-01 |
PublicationDate_xml | – month: 05 year: 2014 text: 2014-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: England – name: Baltimore |
PublicationTitle | Inflammatory bowel diseases |
PublicationTitleAlternate | Inflamm Bowel Dis |
PublicationYear | 2014 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Benus (R25-10-20140418) 2010; 104 Moore (R29-10-20140418) 1997; 41 Jorgensen (R31-10-20140418) 2001; 46 Sartor (R4-10-20140418) 2008; 134 Geypens (R33-10-20140418) 1997; 41 Whelan (R6-10-20140418) 2004; 63 Strocchi (R17-10-20140418) 1992; 15 Ruemmele (R3-10-20140418) 2000; 136 Sokol (R18-10-20140418) 2006; 12 Shiga (R9-10-20140418) 2012; 44 Gerasimidis (R13-10-20140418) 2012; 18 Seksik (R19-10-20140418) 2003; 52 El (R37-10-20140418) 1996; 38 Hyams (R15-10-20140418) 1991; 12 Santhanam (R26-10-20140418) 2007; 56 Belenguer (R38-10-20140418) 2007; 73 Leach (R8-10-20140418) 2008; 28 Jia (R10-10-20140418) 2010; 310 Levine (R30-10-20140418) 1998; 93 Buchanan (R12-10-20140418) 2009; 30 Sokol (R23-10-20140418) 2009; 15 Sokol (R22-10-20140418) 2008; 105 Beattie (R2-10-20140418) 1998; 14 Gerasimidis (R14-10-20140418) 2011; 45 Vetrovsky (R20-10-20140418) 2013; 8 Lewis (R34-10-20140418) 2007; 102 Hansen (R24-10-20140418) 2013; 8 Moore (R32-10-20140418) 1998; 43 Whelan (R39-10-20140418) 2005; 135 Sartor (R5-10-20140418) 2011; 4 Fiorucci (R35-10-20140418) 2006; 131 Lionetti (R7-10-20140418) 2005; 29 Silverberg (R21-10-20140418) 2005; 19 Cameron (R1-10-20140418) 2013; 37 Laurentin (R16-10-20140418) 2004; 43 Fiorucci (R36-10-20140418) 2007; 150 Roediger (R27-10-20140418) 1980; 2 Thibault (R28-10-20140418) 2007; 133 Tjellstrom (R11-10-20140418) 2012; 47 24859301 - Inflamm Bowel Dis. 2014 Jul;20(7):E18. doi: 10.1097/MIB.0000000000000071. 24859302 - Inflamm Bowel Dis. 2014 Jul;20(7):E18-9. doi: 10.1097/MIB.0000000000000079. |
References_xml | – volume: 47 start-page: 1454 year: 2012 ident: R11-10-20140418 publication-title: Scand J Gastroenterol doi: 10.3109/00365521.2012.703234 – volume: 2 start-page: 712 year: 1980 ident: R27-10-20140418 – volume: 15 start-page: 75 year: 1992 ident: R17-10-20140418 publication-title: J Microbiol Methods doi: 10.1016/0167-7012(92)90071-B – volume: 105 start-page: 16731 year: 2008 ident: R22-10-20140418 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0804812105 – volume: 18 start-page: 1672 year: 2012 ident: R13-10-20140418 publication-title: Inflamm Bowel Dis doi: 10.1002/ibd.21916 – volume: 14 start-page: 345 year: 1998 ident: R2-10-20140418 publication-title: Nutrition doi: 10.1016/S0899-9007(97)00493-0 – volume: 133 start-page: 1916 year: 2007 ident: R28-10-20140418 publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.08.041 – volume: 41 start-page: 77 year: 1997 ident: R29-10-20140418 publication-title: Gut doi: 10.1136/gut.41.1.77 – volume: 150 start-page: 996 year: 2007 ident: R36-10-20140418 publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0707193 – volume: 12 start-page: 439 year: 1991 ident: R15-10-20140418 publication-title: J Pediatr Gastroenterol Nutr doi: 10.1097/00005176-199105000-00005 – volume: 52 start-page: 237 year: 2003 ident: R19-10-20140418 publication-title: Gut doi: 10.1136/gut.52.2.237 – volume: 8 start-page: e57923 year: 2013 ident: R20-10-20140418 publication-title: PLoS One doi: 10.1371/journal.pone.0057923 – volume: 131 start-page: 259 year: 2006 ident: R35-10-20140418 publication-title: Gastroenterology doi: 10.1053/j.gastro.2006.02.033 – volume: 30 start-page: 501 year: 2009 ident: R12-10-20140418 publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2009.04067.x – volume: 56 start-page: 1543 year: 2007 ident: R26-10-20140418 publication-title: Gut doi: 10.1136/gut.2006.108449 – volume: 102 start-page: 624 year: 2007 ident: R34-10-20140418 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2006.01020.x – volume: 134 start-page: 577 year: 2008 ident: R4-10-20140418 publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.11.059 – volume: 29 start-page: S173 year: 2005 ident: R7-10-20140418 publication-title: JPEN J Parenter Enteral Nutr doi: 10.1177/01486071050290S4S173 – volume: 19 start-page: 5 year: 2005 ident: R21-10-20140418 publication-title: Can J Gastroenterol doi: 10.1155/2005/269076 – volume: 43 start-page: 183 year: 2004 ident: R16-10-20140418 publication-title: Eur J Nutr doi: 10.1007/s00394-004-0457-3 – volume: 93 start-page: 83 year: 1998 ident: R30-10-20140418 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.1998.083_c.x – volume: 46 start-page: 1722 year: 2001 ident: R31-10-20140418 publication-title: Dig Dis Sci doi: 10.1023/A:1010661706385 – volume: 43 start-page: 162 year: 1998 ident: R32-10-20140418 publication-title: Dig Dis Sci doi: 10.1023/A:1018848709769 – volume: 12 start-page: 106 year: 2006 ident: R18-10-20140418 publication-title: Inflamm Bowel Dis doi: 10.1097/01.MIB.0000200323.38139.c6 – volume: 8 start-page: e58825 year: 2013 ident: R24-10-20140418 publication-title: PLoS One doi: 10.1371/journal.pone.0058825 – volume: 38 start-page: 870 year: 1996 ident: R37-10-20140418 publication-title: Gut doi: 10.1136/gut.38.6.870 – volume: 4 start-page: 127 year: 2011 ident: R5-10-20140418 publication-title: Mucosal Immunol doi: 10.1038/mi.2010.87 – volume: 63 start-page: 105 year: 2004 ident: R6-10-20140418 publication-title: Proc Nutr Soc doi: 10.1079/PNS2003317 – volume: 44 start-page: 736 year: 2012 ident: R9-10-20140418 publication-title: Dig Liver Dis doi: 10.1016/j.dld.2012.04.014 – volume: 73 start-page: 6526 year: 2007 ident: R38-10-20140418 publication-title: Appl Environ Microbiol doi: 10.1128/AEM.00508-07 – volume: 45 start-page: 234 year: 2011 ident: R14-10-20140418 publication-title: J Clin Gastroenterol doi: 10.1097/MCG.0b013e3181f39af5 – volume: 104 start-page: 693 year: 2010 ident: R25-10-20140418 publication-title: Br J Nutr doi: 10.1017/S0007114510001030 – volume: 37 start-page: 622 year: 2013 ident: R1-10-20140418 publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12230 – volume: 15 start-page: 1183 year: 2009 ident: R23-10-20140418 publication-title: Inflamm Bowel Dis doi: 10.1002/ibd.20903 – volume: 41 start-page: 70 year: 1997 ident: R33-10-20140418 publication-title: Gut doi: 10.1136/gut.41.1.70 – volume: 135 start-page: 1896 year: 2005 ident: R39-10-20140418 publication-title: J Nutr doi: 10.1093/jn/135.8.1896 – volume: 136 start-page: 285 year: 2000 ident: R3-10-20140418 publication-title: Nutrition as primary therapy in pediatric Crohns disease: fact or fantasy J Pediatr – volume: 310 start-page: 138 year: 2010 ident: R10-10-20140418 publication-title: Is the abundance of Faecalibacterium prausnitzii relevant to Crohns disease FEMS Microbiol Lett – volume: 28 start-page: 724 year: 2008 ident: R8-10-20140418 publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2008.03796.x – reference: 24859301 - Inflamm Bowel Dis. 2014 Jul;20(7):E18. doi: 10.1097/MIB.0000000000000071. – reference: 24859302 - Inflamm Bowel Dis. 2014 Jul;20(7):E18-9. doi: 10.1097/MIB.0000000000000079. |
SSID | ssj0020209 |
Score | 2.5088015 |
Snippet | The gut microbiota is implicated in the pathogenesis of Crohn’s disease (CD). Exclusive enteral nutrition (EEN) is a successful treatment, but its mode of... The gut microbiota is implicated in the pathogenesis of Crohn's disease (CD). Exclusive enteral nutrition (EEN) is a successful treatment, but its mode of... BackgroundThe gut microbiota is implicated in the pathogenesis of Crohn’s disease (CD). Exclusive enteral nutrition (EEN) is a successful treatment, but its... Background: The gut microbiota is implicated in the pathogenesis of Crohn's disease (CD). Exclusive enteral nutrition (EEN) is a successful treatment, but its... |
SourceID | proquest pubmed crossref oup |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 861 |
SubjectTerms | Adolescent Bacteria Bacteroides Biomarkers - metabolism Case-Control Studies Child Crohn Disease - metabolism Crohn Disease - microbiology Crohn Disease - prevention & control Crohn's disease Enteral Nutrition Faecalibacterium prausnitzii Feces Feces - chemistry Feces - microbiology Female Follow-Up Studies Gastrointestinal Tract - metabolism Gastrointestinal Tract - microbiology Humans Male Metabolites Metabolomics Microbiota Nutrition Prevotella Prognosis Remission Induction |
Title | Decline in Presumptively Protective Gut Bacterial Species and Metabolites Are Paradoxically Associated with Disease Improvement in Pediatric Crohn’s Disease During Enteral Nutrition |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24651582 https://www.proquest.com/docview/3169802400 https://www.proquest.com/docview/1518618367 https://www.proquest.com/docview/1680457006 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NatwwEB7aBEovpf_dJA0q9NCLiVeSbfkUstmkaWGXEBrYm5GlWVIIdrr2Qnrra_RJ-j59kowk2yEtpN2bdrWWYUYz3_wDvNdIrJssySwpS4wk6YxIJbmJDKnyZFlaHhtXnDybpyfn8vMiWXQOt6ZLq-xlohfUtjbOR74nxmmuXEOueP_qW-SmRrnoajdC4yFs-tZlxM_Z4tbgikOKB1k4LsSfq750Ls_2Zp8moXXh8OHijmq6U-72F-r02uf4KTzpYCM7CHR-Bg-weg6PZl1g_AX8mqKrcUT2tWIuq4KI5OTY5Xda-UYMtGAf1y2bhO7M9Cw_eR4bpivLZtgSM7hy5IbOQHaqV9rW146A9IiehGiZc9uyaQjqsOCQ8P5Ff24_9YMdruqL6vePn82wdeqrIZlPQaCz5_0MgJdwfnz05fAk6mYyREYmso0IP9iUI0pFlqNOJel7JQnylURYMjY1KlW6lu0aTUyKLxFcC5ubLDFoNMEP8Qo2qrrCN8Binmupl3JpUUg9xlyIsc2sSGMjOX03AtGTozBdw3I3N-Oy6APnRMTiTyKOIBr-dRUadvxj_wei9H9u3enZoehuelPc8uUI3g0_0x11gRddYb1uCkJVKiXZmWb37EkVoeuMhOAIXgdWG16K-4H1im_d_wLb8JjgnAzpmDuw0a7W-JYgU1vu-nuxC5uTo_npGa2mZ_wG11MSdg |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELbKVgIuiH8WChgJJC5Rs7aTOAeE2G7LLm1WFWql3lLHnhVIVVI2WUFvvAYvwZX34UkYx3FQQSpcurdsHNvSfJ4fzx8hzxUgdKMFmiVFAYFAmRHIKNWBRlEeLQrDQm2Tk7N5PD0U746iozXy3efC2LBKzxNbRm0qbe_IN_koTqUtyBW-Pv0U2K5R1rvqW2g4WOzC2Wc02epXswnS9wVjO9sHW9Og6yoQaBGJJkAJaGIGICTaPioWKLGkQKWlwK2huaRAysIWHVegQ2TdEWeKm1QnkQatUIBynPcKWRc2o3VA1sfb8_33vYkXuqAStKlsUEEqfbJemmxms7Erltj_GD8nDM8l2P2l57bybucmudEpqvSNQ9YtsgblbXI161zxd8iPCdisSqAfS2rjOBAWlnOenOFTW_oBH-jbVUPHrh40ztX2uoeaqtLQDBqEn02ArnENoPtqqUz1xUIGp_CgAUPtRTGdODcSdVcg7Y1mu67vM0K3ltWH8ufXb3U_dNLmX9I26AHXnvuuA3fJ4aXQ6x4ZlFUJDwgNWaqEWoiFAS7UCFLORyYxPA61YPjfkHBPjlx3JdJtp46T3LvqkYj5n0QckqD_6tSVCPnH-JdI6f8cuuHhkHe8pc5_n4Qheda_Rq5gXT2qhGpV56jHyRi5dZxcMCaWqM8nyHaH5L6DWr8pJmJUdCV7ePEGnpJr04NsL9-bzXcfkeuoTAoXDLpBBs1yBY9RYWuKJ90poeT4sg_mL09QTKA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Decline+in+presumptively+protective+gut+bacterial+species+and+metabolites+are+paradoxically+associated+with+disease+improvement+in+pediatric+Crohn%27s+disease+during+enteral+nutrition&rft.jtitle=Inflammatory+bowel+diseases&rft.au=Gerasimidis%2C+Konstantinos&rft.au=Bertz%2C+Martin&rft.au=Hanske%2C+Laura&rft.au=Junick%2C+Jana&rft.date=2014-05-01&rft.issn=1536-4844&rft.eissn=1536-4844&rft.volume=20&rft.issue=5&rft.spage=861&rft_id=info:doi/10.1097%2FMIB.0000000000000023&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-0998&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-0998&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-0998&client=summon |